KARYOPHARM THERAPEUTICS INC's ticker is KPTI and the CUSIP is 48576U106. A total of 141 filers reported holding KARYOPHARM THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.42 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $672,411 | +129.0% | 501,799 | +205.9% | 0.00% | 0.0% |
Q2 2023 | $293,628 | -6.2% | 164,038 | +103.7% | 0.00% | 0.0% |
Q1 2023 | $313,196 | +49.4% | 80,513 | +30.6% | 0.00% | – |
Q4 2022 | $209,600 | -65.9% | 61,647 | -45.3% | 0.00% | -100.0% |
Q3 2022 | $615,000 | +502.9% | 112,676 | +398.1% | 0.00% | – |
Q2 2022 | $102,000 | -50.2% | 22,622 | -18.7% | 0.00% | – |
Q1 2022 | $205,000 | -84.0% | 27,830 | -68.3% | 0.00% | -100.0% |
Q3 2020 | $1,281,000 | -25.8% | 87,761 | -3.7% | 0.00% | -33.3% |
Q2 2020 | $1,726,000 | +50.5% | 91,121 | +52.6% | 0.00% | +50.0% |
Q1 2020 | $1,147,000 | +416.7% | 59,714 | +415.0% | 0.00% | – |
Q4 2019 | $222,000 | -7.5% | 11,594 | -54.7% | 0.00% | – |
Q4 2018 | $240,000 | -54.2% | 25,596 | -16.8% | 0.00% | -100.0% |
Q3 2018 | $524,000 | +61.2% | 30,767 | +60.6% | 0.00% | – |
Q2 2018 | $325,000 | -25.3% | 19,153 | +34.9% | 0.00% | -100.0% |
Q1 2015 | $435,000 | -4.0% | 14,200 | +17.4% | 0.00% | 0.0% |
Q4 2014 | $453,000 | – | 12,100 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
AIGH Capital Management LLC | 1,773,474 | $2,376,456 | 1.12% |
AlphaCentric Advisors LLC | 1,125,000 | $1,507,500 | 0.86% |
Tejara Capital Ltd | 1,077,388 | $1,443,700 | 0.82% |
Palo Alto Investors LP | 5,675,876 | $7,605,674 | 0.72% |
Birchview Capital, LP | 571,832 | $766,255 | 0.65% |
Altium Capital Management LP | 740,000 | $991,600 | 0.52% |
Avidity Partners Management LP | 8,298,570 | $11,120,084 | 0.45% |
Worth Venture Partners, LLC | 445,981 | $597,615 | 0.36% |
SILVERARC CAPITAL MANAGEMENT, LLC | 561,955 | $753,020 | 0.23% |
DAFNA Capital Management LLC | 192,678 | $258,189 | 0.08% |